Clinical Research Directory
Browse clinical research sites, groups, and studies.
Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study
Sponsor: Memorial Sloan Kettering Cancer Center
Summary
The purpose of this study is to see if Cs-131 brachytherapy is effective in people with recurrent brain cancer who are scheduled to have brain surgery for removal of their tumor(s). The researchers would like to see whether Cs-131 prevents brain tumors from growing back after surgery.The researchers will compare Cs-131 brachytherapy (which occurs during brain surgery) with the usual approach of brain surgery without brachytherapy. The researchers will compare both the effectiveness and safety of the two approaches.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
103
Start Date
2020-12-24
Completion Date
2026-12
Last Updated
2026-01-13
Healthy Volunteers
No
Conditions
Interventions
Craniotomy
Craniotomy
Cesium-131 brachytherapy
Intracavitary Cesium-131 brachytherapy
Locations (6)
Baptist Health South Florida
Miami, Florida, United States
Memorial Sloan Kettering at Basking Ridge (Consent Only)
Basking Ridge, New Jersey, United States
Memorial Sloan Kettering Monmouth (Consent Only)
Middletown, New Jersey, United States
Memorial Sloan Kettering Commack (Consent Only)
Commack, New York, United States
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Memorial Sloan Kettering Nassau (Limited Protocol Activities)
Uniondale, New York, United States